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Abstract
The molecular mechanisms underlying cerebral angiogenesis have not been fully investigated. Using primary mouse brain
endothelial cells (MBECs) and a capillary-like tube formation assay, we investigated whether the sonic hedgehog (Shh)
signaling pathway is coupled with the plasminogen/plasmin system in mediating cerebral angiogenesis. We found that
incubation of MBECs with recombinant human Shh (rhShh) substantially increased the tube formation in naı ¨ve MBECs. This
was associated with increases in tissue plasminogen activator (tPA) activation and reduction of plasminogen activator
inhibitor 1 (PAI-1). Blockage of the Shh pathway with cyclopamine abolished the induction of tube formation and the effect
of rhShh on tPA and PAI-1. Addition of PAI-1 reduced rhShh-augmented tube formation. Genetic ablation of tPA in MBECs
impaired tube formation and downregulated of vascular endothelial growth factor (VEGF) and angiopoietin 1 (Ang1).
Addition of rhShh to tPA2/2 MBECs only partially restored the tube formation and upregulated Ang1, but not VEGF,
although rhShh increased VEGF and Ang1 expression on wild-type MBECs. Complete restoration of tube formation in tPA2/
2 MBECs was observed only when both exogenous Shh and tPA were added. The present study provides evidence that tPA
and PAI-1 contribute to Shh-induced in vitro cerebral angiogenesis.
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Introduction
Stroke induces angiogenesis during the process of brain repair,
and angiogenesis in the ischemic brain is related to improvement
of functional outcome [1,2,3,4]. Angiogenesis consists of a series of
endothelial cellular events, including proliferation, migration,
formation of tube like structures, and maturation into new blood
vessels [5,6]. Molecular mechanisms underlying cerebral angio-
genesis have not been extensively investigated.
Sonic hedgehog (Shh), a member of the family of the hedgehog
proteins [7], mediates angiogenesis during development [8,9] and
under pathological conditions [10,11,12]. Shh binds to its
transmembrane receptor Patched (Ptch) [12] that results in the
activation of the transmembrane protein smoothened (Smo), and
subsequently triggers an intracellular signal transduction pathway
that leads to the activation of the Gli transcription factors [7]. Shh
has been implicated in the induction of cerebral angiogenesis
[13,14]. Shh mediates neural tube angiogenesis during embryonic
development [14]. In vitro, Shh induces capillary tube formation
in a murine brain capillary endothelial cell line [13].
Plasminogen activators, tPA and urokinase plasminogen
activator (uPA), convert plasminogen into plasmin [15]. Plasmin
regulates angiogenesis directly by degrading matrix molecules and
indirectly by activating extracellular matrix metalloproteinases and
angiogenic growth factors [16,17]. Plasminogen activator inhibitor
1 (PAI-1) also plays a critical angiogenic role [18,19,20]. In the
cerebral circulation, cerebral endothelial cells are primary
contributors of tPA and PAI-1 [21].
We and others have recently demonstrated that astrocytes
secrete Shh and cerebral endothelial cells express Ptch, Smo, and
Gli1 [22,23]. Thus, the possibility arises that activation of the Shh
signaling pathway in cerebral endothelial cells by secreted Shh
interacts with tPA and/or PAI to induce angiogenesis. Accord-
ingly, we hypothesized that the interaction between the Shh
signaling pathway and the plasminogen and plasmin system
mediates cerebral angiogenesis. In the present study, using
primary mouse brain endothelial cells (MBECs) and a capillary-
like tube formation assay, we tested this hypothesis. Our data show
that tPA and PAI-1 are required for Shh-induced cerebral
angiogenesis, thereby suggesting that their crosstalk plays an
important in cerebral angiogenesis.
Results
The Shh pathway promotes capillary-like tube formation
in cerebral endothelial cell
Using a capillary tube formation assay, we examined the effect
of Shh on in vitro angiogenesis. Incubation of primary MBECs
with rhShh (100 ng/ml) in Matrigel for 16 h significantly
increased the number of tubes compared with the number in
the control group (Fig. 1A, B, and D). We then examined whether
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Quantitative real-time RT-PCR analysis revealed that treatment
of MBECs with rhShh upregulated mRNA levels of Ptch, a Shh
receptor, and Gli1, a transcription factor (Fig. 1E, F, and Figure
S1 A to D). Blockage of the Shh pathway with a specific inhibitor
of the Smo, cyclopamine (5 mM), abolished the rhShh-increased
tube formation (Fig. 1C, D). These data indicate that exogenous
Shh promotes angiogenesis in naive cerebral endothelial cells.
tPA and PAI-1contribute to Shh-enhanced capillary tube
formation
To examine the effect of rhShh on the plasminogen/plasmin
system, we measured mRNA and protein levels of genes in this
system. Quantitative real-time RT-PCR analysis of naı ¨ve MBECs
revealed that rhShh significantly upregulated tPA (Fig. 2A), but
not uPA expression (Fig. 2B) and downregulated PAI-1 expression
(Fig. 2C) compared with the endothelial cells in the control group.
In parallel, zymography and Western blot analyses showed that
rhShh significantly increased tPA activity (Fig. 2D, E) and protein
levels (Fig. 2F, G), and substantially decreased PAI-1 protein levels
(Fig. 2H, I). Blockage of Smo with cyclopamine suppressed rhShh-
upregulated tPA expression (2.360.2 vs 8.361.1 in rhShh, n=3/
group, p,0.05) and restored PAI-1 expression (1.360.1 vs
0.260.07 in rhShh, n=3/group, p,0.05). These data indicate
that the Shh signaling pathway affects the plasminogen/plasmin
system by activation of tPA and downregulation of PAI-1
expression on MBECs.
We next examined whether activation of tPA by rhShh is
required for rhShh-induced capillary tube formation by employing
primary cerebral endothelial cells harvested from tPA2/2 mice.
Quantitative real-time RT-PCR analysis of the tPA2/2 cerebral
endothelial cells showed that tPA mRNA levels were almost
undetectable (0.0760.01, n=3), while uPA levels were not altered
(1.160.2, n=3) compared to levels on wild-type endothelial cells
(1.060.1, n=3). The capillary tube formation assay showed that
the tPA2/2 endothelial cells exhibited an 87% reduction of
capillary-like tube formation (Fig. 3C, G) compared to wild-type
endothelial cells (Fig. 3A, G). To examine whether exogenous tPA
can restore capillary tube formation of the tPA2/2 endothelial
cells, rhtPA was added. Surprisingly, exogenous rhtPA only
modestly restored capillary tube formation of the tPA2/2
endothelial cells in a dose-dependent manner (Fig. 3E, G, and
H). Addition of rhShh into the tPA2/2 endothelial cells also
modestly increased the tube formation (Fig. 3D, G) compared with
the tPA2/2 endothelial cells (Fig. 3C, G). However, incubation
of the tPA2/2 endothelial cells with both rhtPA and rhShh fully
restored the tube formation, which significantly surpassed tube
formation levels of wild-type endothelial cells (Fig. 3F, G). These
data suggest that tPA and Shh contribute to in vitro cerebral
angiogenesis.
To examine whether PAI-1 contributes to Shh-induced tube
formation, we incubated wild-type endothelial cells with PAI-1
(10 mg/ml) in the presence of rhShh and found that exogenous
PAI-1 significantly reduced rhShh-increased tube formation
(Fig. 4C, D and E), although exogenous PAI-1 alone did not
affect baseline tube formation (Fig. 4A, B, and E). Furthermore,
addition of PAI-1 into tPA2/2 endothelial cells treated with
rhtPA and rhShh partially, but significantly reduced tube
formation (Fig. 3G). These suggest that PAI-1 is also involved in
Shh-induced angiogenesis.
Upregulation of Ang1 and VEGF by Shh is tPA dependent
and independent, respectively
Previous studies have shown that Shh upregulates VEGF and
Ang1 in fibroblasts and interstitial mesenchymal cells [10,11]. We
therefore examined the effect of rhShh on expression of these
genes in cerebral endothelial cells. Both real-time RT-PCR
analysis and Western blot showed that rhShh significantly
upregulated Ang1 and VEGF expression on wild-type endothelial
cells (Fig. 5A to F). Blockage of Tie2 with a neutralizing antibody
against Tie2 significantly reduced rhShh-induced tube formation
(3.961.1 vs 6.460.4 mm/mm
2 in rhShh group, n=5/group,
p,0.05), while inhibition of VEGF receptor 2 (VEGFR2) with
SU1498, a specific antagonist of VEGFR2, did not significantly
Figure 1. Shh increases capillary-like tube formation in primary cerebral endothelial cells isolated from wild-type mice. Panels A to C
show representative images of capillary-like tube formation of primary cerebral endothelial cells incubated with control medium (A), rhShh (B), and
rhShh in presence of cyclopamine (C). Panel D shows quantitative data of capillary-like tube lengths in mm/mm
2 (n=6/group). Real-time RT-PCR
analysis (n=3/group) showed that rhShh substantially increased mRNA levels of Ptch (E), a Shh receptor, and Gli 1(F), a transcription factor in
endothelial cells. *p,0.05 the control group, # p,0.05 versus the rhShh group. Bar=100 mm. WT=wild-type. CY=cyclopamine.
doi:10.1371/journal.pone.0033444.g001
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mm
2 in rhShh group, n=5, p=0.09). Interestingly, tPA2/2
endothelial cells exhibited significant reductions of Ang1 mRNA
and protein (Fig. 5A, C, D), and a significant decrease in VEGF
protein (Fig. 5B, E, F) compared to wild-type endothelial cells,
suggesting that knockout of tPA affects Ang 1 and VEGF
expression. Incubation of tPA2/2 endothelial cells with rhShh
robustly upregulated Ang 1, but did not alter VEGF expression
(Fig. 5A to F). These data suggest that Shh-upregulated Ang1 is
tPA independent, whereas upregulation of VEGF by Shh requires
tPA.
Discussion
The present study demonstrates that Shh promotes in vitro
cerebral angiogenesis and that tPA and PAI-1 are involved in this
process.
A prominent effect of the morphogen Shh on angiogenesis is
emerging. Our observations that rhShh upregulated Gli1 and that
blockage of Smo by cyclopamine abolished the effect of rhShh on
the tube formation indicate that the Shh/Gli1 pathway mediates
cerebral angiogenesis. These data are consistent with a previous
study on mouse brain capillary endothelial cells, which shows that
blockage of cyclopamine suppresses the effect of rhShh on
capillary morphogenesis [13]. We noted that the dose of rhShh
used in the present study (100 ng/ml) was fifty times lower than
the dose in the Kanda et al study (5 mg/ml) [13]. This difference
could be caused by use of different recombinant Shh, rhShh vs
mouse recombinant Shh in the Kanda et al study [13].
Alternatively, primary cerebral endothelial cells used in the
present study are more sensitive to exogenous Shh. A very recent
study shows that rhShh at dose of 0.1 mg/ml regulates blood brain
barrier (BBB) permeability in primary human brain endothelial
cells [22].
Mechanisms by which Shh induces angiogenesis are incom-
pletely understood. The present study indicates a linkage between
the Shh signaling pathway and the plasminogen and plasmin
system in mediating in vitro cerebral angiogenesis. The effect of
exogenous Shh on tPA and PAI-1 is specific because rhShh does
not alter uPA expression and blockage of the Shh pathway with
cyclopamine abolishes tPA activation and restores PAI-1 expres-
sion on cerebral endothelial cells. In addition, both Shh and tPA
are required to fully restore in vitro angiogenesis in tPA2/2
cerebral endothelial cells. Cerebral endothelial cells are primary
sources of tPA and PAI-1 [21]. tPA, a serine protease, converts
plasminogen to plasmin, whereas PAI-1 neutralizes plasminogen
activator activation that prevents the generation of plasmin [24].
The plasminogen and plasmin system regulates angiogenesis
[16,17]. Thus, activation of the Shh signaling pathway could
regulate levels of tPA and PAI-1 on cerebral endothelial cells,
which has also been recently demonstrated by us to occur in
astrocytes [23], suggesting that interaction of the Shh pathway
with the plasminogen/plasmin system is not cell type specific.
Kanda et al previously demonstrated that Shh activates the PI3K
pathway, thereby inducing angiogenesis [13]. The PI3K/Akt
signaling pathway regulates tPA and PAI-1 levels [25]. Additional
Figure 2. Shh increases tPA activity and expression by upregulating tPA expression and downregulating PAI-1 expression. Real-time
RT-PCR analysis (n=3/group) revealed that incubation of endothelia cells with rhShh significantly increased tPA mRNA levels (A) and reduced PAI-1
mRNA (C), but did not alter uPA mRNA levels (B). Zymography and Western blot analysis (n=3/group) showed that rhShh significantly increased PA
activity (D and E), protein expression (F and G), and reduced PAI-1 proteins (H and I), respectively. *p,0.05 compared to the control group. WT=wild-
type.
doi:10.1371/journal.pone.0033444.g002
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pathway mediates crosstalk between the Shh pathway and the
plasminogen/plasmin system.
Consistent with published data, the present study demonstrates
that Shh upregulates proangiogenic factors VEGF and Ang1 on
cerebral endothelial cells [13,14]. Angiogenesis induced by tPA is
mediated by elevation of VEGF [26]. Our data demonstrate that
ablation of tPA substantially reduced endogenous Ang1 and
VEGF expression on cerebral endothelial cells, which could
account for observed impairment of tube formation. Our data
further indicate that Shh regulates VEGF expression on cerebral
endothelial cells in a tPA-dependent manner, as exogenous Shh
could not upregulate VEGF expression on tPA2/2 endothelial
cells. In contrast, endogenous tPA is not required for Shh-induced
Ang1 expression, since rhShh elevated Ang1 levels in tPA2/2
endothelial cells, as rhShh did on wild-type endothelial cells.
Studies in mesenchymal cells suggest that Shh induces Ang1
through activation of the orphan nuclear receptor, COUPTFII
[27]. Thus, the present study reveals coupling of Shh and tPA in
mediating cerebral angiogenesis by regulating proangiogenic
factors. While our manuscript was under review, Alvarez et al
showed that the Shh secreted by astrocytes interacts with cerebral
endothelial cells to facilitate formation of BBB integrity and to
reduce inflammation in vivo [22]. Further studies are needed to
investigate whether coupling of the Shh pathway and the
plasminogen/plasmin system plays a role in BBB function.
In summary, the present study demonstrates that tPA and PAI-1
are involved in Shh-induced in vitro cerebral angiogenesis, which
suggests complex coupling between the Shh signaling pathway and
the plasminogen/plasmin system for inducing angiogenesis.
Materials and Methods
All experimental procedures were approved by the institutional
Animal Care and Use Committee of Henry Ford Hospital. Wild-
type mice (C57BL6/J, 6–8 weeks) and tPA null mice (tPA2/2
Figure 3. tPA activity partially mediated Shh-enhanced capillary tube formation. Panels A to F show representative images of capillary-like
tubeformationofprimary cerebralendothelialcellsincubatedwithcontrolmedium(A),rhShh(B),tPA2/2cerebralendothelialcells(C),tPA2/2cerebral
endothelial cellsincubated with rhShh (D), tPA2/2cerebral endothelial cellsincubated with htPA (E), and), tPA2/2cerebral endothelialcells incubated
with rhShh andhtPA (F). PanelG shows quantitativedata of capillary-like tubelengthsin mm/mm
2 among different experimental groups (n=6/group).
Panel H shows the effect of different doses of exogenous tPA on capillary-like tube formation on tPA2/2 cerebral endothelial cell (n=6/group).
*p,0.05 versus the tPA2/2group, # p,0.05 versus the tPA2/2+tPA group, ‘p,0.05 versus the tPA2/2+Shh group, $ p,0.05 vs the tPA2/
2+tPA+Shh group, & p,0.05 versus the WT group, and + p,0.05 versus the tPA2/2+tPA+Shh group. Bar=100 mm. WT=wild-type. tPA2/2=tPA
knockout.
doi:10.1371/journal.pone.0033444.g003
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Laboratory (Bar Harbor, ME). The permit number is: #886.
Culture of mouse brain microvascular endothelial cells
Cerebral endothelial cells were isolated from microvessels of
wild-type (n=10) or tPA knockout mice (n=10) as previously
described [28]. Briefly, mice were sacrificed and their brains were
collected in RPMI 1640 medium (Invitrogen Cooperation,
Carlsbad, CA) supplemented with 1% penicillin and streptomycin
(Invitrogen Corporation, Carlsbad, CA). Cerebellum, white
matter, meninges, and visible blood vessels of the brain were
removed under a microscope. Cerebral cortex and subcortex were
cut into small pieces and homogenized. Homogenates were
suspended in 15% dextran (Sigma, St. Louis, MO) and centrifuged
at 6,000 g for 15 min at 4uC. Pellets were resuspended and
digested with 0.1% collagenase/dispase (Roche Applied Science,
Penzberg, Germany) and 2% FBS (Invitrogen) in RPMI1640
medium. Digested microvessels were separated with 45% Percoll
(Sigma, St. Louis, MO) at 20,000 g for 10 min at 4uC and plated
into collagen I (BD Biosciences, Bedford, MA) coated plates.
Cultures were maintained in endothelial growth medium. Passage
2–4 endothelial cells were employed in the present study.
Capillary tube formation assay
Ninety-six well plates were coated with 100 ml solution
containing 70% matrigel (BD Biosciences) and 30% DMEM
(Invitrogen). MBECs were incubated with or without rhShh
(100 ng/ml) (R&D System, Minneapolis, MN), cyclopamine
(5 mM) (EMD-Calbiochem, Gibbstown, NJ), rhtPA (1 mM)
(EMD-Calbiochem), or PAI-1 (10 ug/ml) (EMD-Calbiochem)
for 16 h. MBECs (2610
4cells/well) were then seeded in the
coated 96-well plates for 3–4 hours at 37uC. Formation of
capillary-like networks was recorded under a 106 objective
Figure 4. PAI-1 decreased Shh induced tube formation. Panels A
to D show representative images of capillary-like tube formation of
primary cerebral endothelial cells incubated with control medium (A),
PAI-1(B), rhShh (C), and rhShh with PAI-1(D). Panel E shows quantitative
data of capillary-like tube lengths in mm/mm
2 among different
experimental groups (n=5/group).* p,0.05 the control group.
# p,0.05 versus the rhShh group. Bar=100 mm.
doi:10.1371/journal.pone.0033444.g004
Figure 5. The effect of rhShh on expression of VEGF and Ang1 in wild-type and tPA2/2 MBECs. Real-time RT-PCR (A, B) and Western blot
(C to F) analyses showed that rhShh robustly increased Ang1 (A, C, D) and VEGF (B, E, F) expression in wild-type (WT) MBECs. Knockout of tPA (tPA2/2)
substantially reduced Ang1 expression compared with wild-type MBECs (A, C, D), whereas incubation of tPA2/2 MBECs with rhShh completely rescued
Ang1 expression (A, C, D). However, incubation of tPA2/2 MBECs with rhShh did not elevate VEGF expression, although knockout tPA significantly
reduced VEGF protein levels (B, E, F). * p,0.05 versus the WT group, # p,0.05 versus the tPA2/2 group. (n=3/group). MBECs=mouse brain
endothelial cells.
doi:10.1371/journal.pone.0033444.g005
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color CoolSnap CCD camera (Roper Scientific Photometrics,
Tucson, Arizona) and the total length of tube formation was
measured by means of the microcomputer imaging device (MCID,
Imaging Research, St. Catharines, Canada). Data are presented as
the length in mm/mm
2.
Real time RT-PCR
Quantitative real-time RT-PCR was performed according to
published methods [28,29]. Briefly, total RNA from MBECs was
isolated using Absolutely RNA Microprep Kit (Stratagene, La
Jolla, CA) and followed by reverse transcription in accordance
with the manufacturer’s procedure. Real-time PCR was per-
formed using SYBR Green PCR Master Mix (Applied Biosystems,
Foster City, CA) on an ABI 7000 PCR instrument (Applied
Biosystems). Three-stage program parameters provided by the
manufacturer were employed, as follows: 2 min at 50uC, 10 min
at 95uC, and then 40 cycles of 15 s at 95uC and 1 min at 60uC.
The specificity of PCR product was verified by performing
dissociation reaction plots. Each sample was tested in triplicate and
data obtained from three independent experiments were used to
quantify relative gene expression by the 2
2DDCt method. Using
Primer Express software (Applied Biosystems), we designed the
following primers used in the present study: b-actin (forward, 59-
CCA TCA TGA AGT GTG ACG TTG-39; reverse, 59-CAA
TGA TCT TGA TCT TCA TGG TG-39), tPA (forward, 59-CTG
AGG TCA CAG TCC AAG CA-39; reverse, 59- ACA GAT GCT
GTG AGG TGC AG-39), PAI-1 (forward, 59-GTC TTT CCG
ACC AAG AGC AG-39; reverse, 59- ATC ACT TGG CCC ATG
AAG AG-39), uPA(forward, 59- AGT GTG GCC AGA AGG
CTC TA-39; reverse, 59- GCT GCT CCA CCT CAA ACT TC-
39), Ptch1(forward, 59-GTG GAA GTT GGT GGA CGA GT-39;
reverse, 59-TAG CGC CTT CTT CTT TTG GA-39), Gli1(for-
ward, 59-TCC ACA CGC CCC CTA GTG-39; reverse, 59-TGG
CAA CAT TTT CGG TGA TG-39), angiopoietin 1 (Ang1,
forward, 59-CTC GTC AGA CAT TCA TCA TCC AG-39,
reverse, 59-CAC CTT CTT TAG TGC AAA GGC T-39),
vascular endothelial growth factor (VEGF, forward, 59-CAG GCT
GCT GTA ACG ATG AA-39; reverse, 59-GCA TTC ACA TCT
GCT GTG CT-39).
Western blot analysis
Western blot was performed according to published methods
[30]. Briefly, equal amounts of protein (40 mg/lane) for each
sample were electrophoresed through a 10% SDS-PAGE gel
(Invitrogen) and subsequently electrotransferred to nitrocellulose
membranes. Membranes were probed with the following primary
antibodies: PAI-1(1:500, Santa Cruz Biotechnology Inc, Santa
Cruz, CA), tPA(1:500, Santa Cruz), Ang 1 (1:1,000, Abcam,
Cambridge, MA), VEGF (1:500, Santa Cruz), and b-actin
(1:10,000, Abcam) for 16 hrs at 4uC. For detection, horseradish
peroxidase-conjugated secondary antibodies were used (1:2000)
followed by enhanced chemiluminescence development (Pierce,
Rockford, IL).
Direct casein zymography of plasminogen activator (PA)
activity
Proteins from MBECs were separated by 10% SDS-PAGE and
PA activity was assayed by zymography, as described previously
[31,32]. Briefly, 30 mg protein samples were mixed with the
sample loading buffer without b-ME, and heating was omitted.
The mixture of the lower gel (10% acrylamide) contained casein
(1 mg/ml) (Sigma) and plasminogen (13 mg/ml) (American
Diagnostica, Greenwich, CT) as substrates for plasmin and PA,
respectively. The gel was then washed for 30 min with 2.5%
Triton X-100 to remove SDS and further washed for 10 min with
0.1 M Tris buffer, pH 8. New Tris buffer was replaced and the gel
was incubated for 4 hrs at 37uC to allow caseinolysis occur. On the
darkly stained casein background, PA activity was visualized as
light bands resulting from casein degradation. To verify loading
variations, duplicate samples were used in PAI-1 Western blot.
Actin levels were employed as loading control.
Statistical analysis
Student’s t-test was used to analyze data between two groups.
To study the combination factor effect on angiogenesis, two-
factorial design and 2-way ANOVA were considered. Statistical
significance was set at p,0.05.
Supporting Information
Figure S1 Representative real-time RT-PCR raw data of
reaction (A, C) and dissociation curve (B, D) of Ptch (A, B) and
Gli1 (C, D). WT=wild-type.
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